|Table of Contents|

Clinical analysis of thyroid papillary carcinoma with cervical Ⅵ region lymph node metastasis

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 01
Page:
45-47
Research Field:
Publishing date:

Info

Title:
Clinical analysis of thyroid papillary carcinoma with cervical Ⅵ region lymph node metastasis
Author(s):
Wang Wenchao; Yang Li; Zhang Chunxia
Department of the Second General Surgery，Shunyi Hospital，Beijing 101300，China.
Keywords:
thyroid papillary carcinoma; lymph node; metastasis
PACS:
R736.1
DOI:
10.3969/j.issn.1672-4992.2017.01.012
Abstract:
Objective：To analyze the clinical features of the patients with thyroid papillary carcinoma(TPC）combined with cervical Ⅵ region lymph node metastasis and the relationship with the clinical factors.Methods：We performed a retrospective analysis of the clinical data of 121 patients presenting with TPC.There were 56 patients who were combined with cervical Ⅵ region lymph node metastasis.Results：The larger the maximum diameter of the tumor in patients with TPC was associated with greater risk of the possibility of suffering cervical Ⅵ region lymph node metastasis(P<0.05).The possibility of suffering cervical Ⅵ region lymph node metastasis increased when the nodules located in isthmus or the tumor penetrating through the thyroid capsule(P<0.05).The gender，age and the number of tumor were not correlated with the possibility of cervical Ⅵ region lymph node metastasis(P>0.05).Conclusion：For the patient with TPC，the size，location of the tumor or the tumor penetrating through the thyroid capsule are important indicators for auxiliary assessment whether or not be combined with cervical Ⅵ region lymph node metastasis.

References:

［1］Vayisoglu Y，Ozcan C.Involvement of level IIb lymph node metastasis and dissection in thyroid cancer［J］.Gland Surg，2013，2(4)：180-185.
［2］Davidson HC，Park BJ，Johnson JT.Papillary thyroid cancer：controversies in the management of neck metastasis［J］.Laryngoscope，2008，118(12)：2161-2165.
［3］Shaha AR.Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer［J］.Laryngoscope，2004，114(3)：393-402.
［4］Cooper DS，Doherty GM，Haugen BR，et al.American thyroid association(ATA）guidelines taskforce on thyroid nodules and differentiated thyroid cancer.revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer［J］.Thyroid，2009，19(11)：1167-1214.
［5］Koo BS，Choi EC，Yoon YH，et al.Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma［J］.Ann Surg，2009，249(5)：840-844.
［6］Yu XM，Wan Y，Sippel RS，et al.Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18，445 cases［J］.Ann surg，2011，254(4)：653-660.
［7］Kutler DI，Crummey AD，Kubel WI.Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma［J］.Head Neck，2012，34(2)：260-263.
［8］Wang Q，Chu B，Zhu J，et al.Clinical analysis of prophylactic central neck dissection for papillary thyroid carcinoma［J］.Clin Transl Oncol，2014，16(1)：44-48.
［9］Vasileiadis I，Boutzios G，Charitoudis G，et al.Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma［J］.Ann Surg Oncol，2014，21(8)：2725-2732.
［10］Campennì A，Giovanella L，Siracusa M，et al.Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer［J］? Thyroid，2014，24(11)：1607-1611.
［11］Sun RH，Li C，Fan JC，et al.Relationship of tumor location and other clinicopathological features with differentiated thyroid cancer with lymph node metastasis［J］.Cancer Res Prev Treat，2014，41(9)：993-997.［孙荣昊，李超，樊晋川，等.肿瘤位置等临床病理特征与分化型甲状腺癌淋巴结转移的关系［J］.肿瘤防治研究，2014，41(9)：993-997.］

Memo

Memo:
-
Last Update: 2016-12-01